WO2002000721A3 - Cytokine receptor zcytor17 - Google Patents

Cytokine receptor zcytor17 Download PDF

Info

Publication number
WO2002000721A3
WO2002000721A3 PCT/US2001/020484 US0120484W WO0200721A3 WO 2002000721 A3 WO2002000721 A3 WO 2002000721A3 US 0120484 W US0120484 W US 0120484W WO 0200721 A3 WO0200721 A3 WO 0200721A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
zcytor17
methods
cytokine receptor
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/020484
Other languages
French (fr)
Other versions
WO2002000721A8 (en
WO2002000721A2 (en
Inventor
Cindy A Sprecher
Scott R Presnell
Zeren Gao
Theodore E Whitmore
Joseph L Kuijper
Mark F Maurer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27395968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2002000721(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to ES01952259.8T priority Critical patent/ES2593002T3/en
Priority to CA2412239A priority patent/CA2412239C/en
Priority to DK01952259.8T priority patent/DK1325115T3/en
Priority to AU2001273032A priority patent/AU2001273032A1/en
Priority to JP2002505843A priority patent/JP2004501628A/en
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to EP01952259.8A priority patent/EP1325115B1/en
Publication of WO2002000721A2 publication Critical patent/WO2002000721A2/en
Anticipated expiration legal-status Critical
Publication of WO2002000721A3 publication Critical patent/WO2002000721A3/en
Publication of WO2002000721A8 publication Critical patent/WO2002000721A8/en
Priority to CY20161101064T priority patent/CY1118115T1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Novel polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17, a novel cytokine receptor. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo. The polynucleotides encoding zcytor17, are located on chromosome 5, and can be used to identify a region of the genome associated with human disease states. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
PCT/US2001/020484 2000-06-26 2001-06-26 Cytokine receptor zcytor17 Ceased WO2002000721A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP01952259.8A EP1325115B1 (en) 2000-06-26 2001-06-26 Cytokine receptor zcytor17
CA2412239A CA2412239C (en) 2000-06-26 2001-06-26 Cytokine receptor zcytor17
DK01952259.8T DK1325115T3 (en) 2000-06-26 2001-06-26 CYTOKINRECEPTOR ZCYTOR17
AU2001273032A AU2001273032A1 (en) 2000-06-26 2001-06-26 Cytokine receptor zcytor17
JP2002505843A JP2004501628A (en) 2000-06-26 2001-06-26 Cytokine receptor ZCYTOR17
ES01952259.8T ES2593002T3 (en) 2000-06-26 2001-06-26 ZCYTOR17 cytokine receptor
CY20161101064T CY1118115T1 (en) 2000-06-26 2016-10-21 ZCYTOR17 CYCLINE RECEPTOR17

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US21428200P 2000-06-26 2000-06-26
US60/214,282 2000-06-26
US21495500P 2000-06-29 2000-06-29
US60/214,955 2000-06-29
US26796301P 2001-02-08 2001-02-08
US60/267,963 2001-02-08

Publications (3)

Publication Number Publication Date
WO2002000721A2 WO2002000721A2 (en) 2002-01-03
WO2002000721A3 true WO2002000721A3 (en) 2003-04-17
WO2002000721A8 WO2002000721A8 (en) 2016-01-28

Family

ID=27395968

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/020484 Ceased WO2002000721A2 (en) 2000-06-26 2001-06-26 Cytokine receptor zcytor17

Country Status (10)

Country Link
US (1) US20070105777A1 (en)
EP (2) EP1325115B1 (en)
JP (1) JP2004501628A (en)
AU (1) AU2001273032A1 (en)
CA (1) CA2412239C (en)
CY (1) CY1118115T1 (en)
DK (1) DK1325115T3 (en)
ES (1) ES2593002T3 (en)
PT (1) PT1325115T (en)
WO (1) WO2002000721A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005921B2 (en) 2007-12-07 2015-04-14 Zymogenetics, Inc. Polynucleotides encoding IL-31 monoclonal antibodies

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2325316B8 (en) 1999-06-02 2017-04-19 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, NR10
AU7445900A (en) 1999-09-27 2001-04-30 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, nr12
US20030096339A1 (en) 2000-06-26 2003-05-22 Sprecher Cindy A. Cytokine receptor zcytor17
CA2412239C (en) 2000-06-26 2013-05-28 Zymogenetics, Inc. Cytokine receptor zcytor17
AU2002223182B2 (en) * 2000-10-06 2007-08-30 Immunex Corporation Hematopoietin receptors HPR1 and HPR2
WO2002077230A1 (en) * 2001-03-26 2002-10-03 Chugai Seiyaku Kabushiki Kaisha Nr10 splicing variants
EP2840089A1 (en) * 2002-01-18 2015-02-25 ZymoGenetics, Inc. Cytokine receptor zcytor17 multimers
DK1961811T3 (en) 2002-01-18 2010-11-08 Zymogenetics Inc Cytokine ligand for the treatment of asthma and respiratory hyperresponsiveness
US9738700B2 (en) 2002-01-18 2017-08-22 Zymogenetics Inc. ZCYTOR17 heterodimeric cytokine receptor
SI1485477T1 (en) * 2002-02-25 2009-10-31 Genentech Inc Novel type-1 cytokine receptor glm-r
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
JP2007068402A (en) * 2003-12-26 2007-03-22 Bml Inc Immune response regulatory protein
EP1858924A1 (en) * 2005-02-14 2007-11-28 ZymoGenetics, Inc. Methods of treating skin disorders using an il-31ra antagonist
KR101443050B1 (en) 2005-05-06 2014-09-22 지모제넥틱스, 인코포레이티드 Il-31 monoclonal antibodies and methods of use
US20130216542A1 (en) 2005-05-06 2013-08-22 Zymogenetics, Inc. Variable region sequences of il-31 monoclonal antibodies and methods of use
US8101183B2 (en) 2005-05-06 2012-01-24 Zymogentics, Inc. Variable region sequences of IL-31 monoclonal antibodies
EP2749571A3 (en) 2006-01-10 2014-08-13 ZymoGenetics, Inc. Methods of treating pain and inflammation in neuronal tissue using IL-31RA and OSMRb antagonists
ES2429407T3 (en) 2006-06-08 2013-11-14 Chugai Seiyaku Kabushiki Kaisha Preventive agent or remedy for inflammatory diseases
ES2548714T3 (en) 2006-09-01 2015-10-20 Zymogenetics, Inc. IL-31 monoclonal antibodies and use procedures
CA2708065C (en) 2007-12-05 2015-02-24 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for pruritus
JP5954916B1 (en) 2015-04-14 2016-07-20 中外製薬株式会社 A pharmaceutical composition for preventing and / or treating atopic dermatitis, comprising an IL-31 antagonist as an active ingredient
MX2022005654A (en) 2019-11-20 2022-06-22 Chugai Pharmaceutical Co Ltd PREPARATION CONTAINING ANTIBODY.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000075314A1 (en) * 1999-06-02 2000-12-14 Chugai Research Institute For Molecular Medicine, Inc. Novel hemopoietin receptor protein nr10

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615974A (en) 1981-08-25 1986-10-07 Celltech Limited Yeast expression vectors
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
DE3578435D1 (en) 1984-12-06 1990-08-02 Labofina Sa PROMOTORS FOR THE EXPRESSION OF FOREIGN GENES IN YEAST, PLASMIDES THAT CONTAIN THESE PROMOTORS AND THEIR USE FOR THE PRODUCTION OF POLYPEPTIDES.
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
DE68926888T2 (en) 1988-01-22 1997-01-09 Zymogenetics Inc Process for the production of secreted receptor analogs
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5124263A (en) 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
CA2097291A1 (en) 1990-12-13 1992-06-14 David P. Gearing Leukemia inhibitory factor receptors
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
WO1994006463A1 (en) 1992-09-14 1994-03-31 Pfizer Inc Immortalized cells and uses therefor
AU7477394A (en) 1993-07-30 1995-03-27 University Of Medicine And Dentistry Of New Jersey Efficient gene transfer into primary lymphocytes
AU700185B2 (en) 1994-02-14 1998-12-24 Zymogenetics Inc. Method for preparing orphan receptor ligands
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5965389A (en) 1995-11-09 1999-10-12 Zymogenetics, Inc. Production of GAD65 in methylotrophic yeast
JP2002514049A (en) 1996-07-17 2002-05-14 ザイモジェネティクス，インコーポレイティド Production of auxotrophic mutants of Pichia methanolica
JP2002515746A (en) 1996-07-17 2002-05-28 ザイモジェネティクス，インコーポレイティド Transformation of Pichia methanolica
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
WO1999009175A1 (en) * 1997-08-15 1999-02-25 E.I. Du Pont De Nemours And Company Plant genes encoding dr1 and drap1, a global repressor complex of transcription
PT1181366E (en) 1999-06-01 2009-05-25 Schering Corp Mammalian receptor proteins; related reagents and methods
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
CA2412239C (en) 2000-06-26 2013-05-28 Zymogenetics, Inc. Cytokine receptor zcytor17
US20030096339A1 (en) 2000-06-26 2003-05-22 Sprecher Cindy A. Cytokine receptor zcytor17

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000075314A1 (en) * 1999-06-02 2000-12-14 Chugai Research Institute For Molecular Medicine, Inc. Novel hemopoietin receptor protein nr10
EP1188830A1 (en) * 1999-06-02 2002-03-20 Chugai Research Institute for Molecular Medicine Inc. Novel hemopoietin receptor protein nr10

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAZAN J F: "STRUCTURAL DESIGN AND MOLECULAR EVOLUTION OF A CYTOKINE RECEPTOR SUPERFAMILY", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 87, September 1990 (1990-09-01), pages 6934 - 6938, XP000864534, ISSN: 0027-8424 *
DATABASE EMBL [online] 26 March 2001 (2001-03-26), MAEDA M AND YAGUCHI N: "Human haemopoietin receptor protein NR10.3 encoding cDNA SEQ ID NO:16", XP002215726, retrieved from E.B.I., HINXTON, U.K. Database accession no. AAC92350 *
DATABASE EMBL [online] 26 March 2001 (2001-03-26), MAEDA M AND YAGUCHI N: "Human haemopoietin receptor protein NR10.3 SEQ ID NO:17", XP002215727, retrieved from E.B.I., HINXTON, U.K. Database accession no. AAB51244 *
MAHAIRAS GREGORY G ET AL: "Sequence-tagged connectors: A sequence approach to mapping and scanning the human genome", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 96, no. 17, 17 August 1999 (1999-08-17), pages 9739 - 9744, XP002175909, ISSN: 0027-8424 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005921B2 (en) 2007-12-07 2015-04-14 Zymogenetics, Inc. Polynucleotides encoding IL-31 monoclonal antibodies

Also Published As

Publication number Publication date
ES2593002T3 (en) 2016-12-05
DK1325115T3 (en) 2016-11-21
WO2002000721A8 (en) 2016-01-28
CA2412239A1 (en) 2002-01-03
US20070105777A1 (en) 2007-05-10
EP1325115B1 (en) 2016-07-27
EP2258725A2 (en) 2010-12-08
WO2002000721A2 (en) 2002-01-03
AU2001273032A1 (en) 2002-01-08
CA2412239C (en) 2013-05-28
JP2004501628A (en) 2004-01-22
EP1325115A2 (en) 2003-07-09
CY1118115T1 (en) 2017-06-28
EP2258725A3 (en) 2014-09-17
PT1325115T (en) 2016-09-28

Similar Documents

Publication Publication Date Title
WO2002000721A3 (en) Cytokine receptor zcytor17
AU2002241533A1 (en) Cytonkine receptor zcytor19
WO2000017235A3 (en) Cytokine receptor zalpha11
EP1749888A3 (en) Soluble zalpha11 cytokine receptors
WO2000053761A3 (en) Human cytokine as ligand of the zalpha receptor and uses thereof
WO2002012345A3 (en) Soluble zcytor 11 cytokine receptors
WO2003060090A3 (en) Novel cytokine zcytor17 ligand
IL163067A (en) Isolated heterodimeric cytokine receptor
EP0821728A4 (en) Tie-2 ligands, methods of making and uses thereof
GR3035717T3 (en) Tie-2 ligands, methods of making and uses thereof
DK0842273T3 (en) Receptor ligand VGEF-C
ATE371735T1 (en) HEMATOPOIETIC CYTOKINE RECEPTOR
EP0849361A3 (en) Novel ligands of the neuropeptide receptor HFGAN72
MXPA03000227A (en) Novel compounds.
IL127623A0 (en) Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses
WO1992016623A3 (en) Receptors for bombesin-like peptides
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
WO2002026193A3 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
EP1736545A3 (en) Soluble zcytor 11 cytokine receptors
WO1999046381A3 (en) Human fgf gene and gene expression products
WO2000046241A3 (en) Prostate, testis and uterine polypeptide zpep14
EP0844305A3 (en) hRAD54
WO2001042292A3 (en) Secreted polypeptide zsig87
WO2002000825A3 (en) A novel polypeptide, a nuclear receptor protein stromal antigene 110.34 and the polynucleotide encoding the polypeptide
UA84540C2 (en) Novel cytokine zcytor17 ligand

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2412239

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2002 505843

Country of ref document: JP

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2001952259

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001952259

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001952259

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)